{
  "company": {
    "name": "Tulavi Therapeutics",
    "website": "https://tulavi.com/",
    "record": "https://startuphistory.org/c/tulavi.com"
  },
  "status": null,
  "history_since": "2026-11-12T12:06:27.074Z",
  "baseline": {
    "snapshot_id": "2a474cf115065ff3e531864aa8b4d5a68c1c302d647a75bb78e5e8974ff9c98e",
    "observed_at": "2026-11-12T12:06:27.074Z",
    "headline": "Redefining Peripheral Nerve Surgery",
    "description": "Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve healing to address poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair.",
    "evidence": "https://tulavi.com/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T12:06:27.074Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-12T12:06:27.074Z",
      "variants": [
        {
          "headline": "Redefining Peripheral Nerve Surgery",
          "subhead": "Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve healing to address poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair.",
          "observed_at": "2026-11-12T12:06:27.074Z",
          "evidence": "https://tulavi.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Redefining Peripheral Nerve Surgery",
      "subhead": "Tulavi’s innovative Adaptive Hydrogel Technology is engineered to support nerve healing to address poor and unpredictable outcomes in neuroma prevention, adhesion reduction, and nerve repair.",
      "from": "2026-11-12T12:06:27.074Z",
      "to": "2026-11-12T12:06:27.074Z",
      "captures": 1,
      "evidence": "https://tulavi.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-12T12:06:27.074Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "ProLynx",
      "record": "https://startuphistory.org/c/prolynxinc.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "BlossomHill Therapeutics",
      "record": "https://startuphistory.org/c/bhtherapeutics.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "Star Therapeutics",
      "record": "https://startuphistory.org/c/star-therapeutics.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "Uncommon Therapeutics",
      "record": "https://startuphistory.org/c/uncommontherapeutics.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "Feldan Therapeutics",
      "record": "https://startuphistory.org/c/feldan.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "Cour Pharmaceuticals Development",
      "record": "https://startuphistory.org/c/courpharma.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Tulavi Therapeutics” company record, https://startuphistory.org/c/tulavi.com"
}